Biomarkers of lung-related diseases: Current knowledge by proteomic approaches

Journal of Cellular Physiology

Volumn 221, Issue 3, 2009, Pages 535-543

  Lau, Andy T Y ^a   Chiu, Jen Fu ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B; CALRETICULIN; CATALASE; CLARA CELL PROTEIN; COLLAGENASE 3; CYTOKINE; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; MUCIN; OVALBUMIN; PROTEIN DISULFIDE ISOMERASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SERUM AMYLOID A; SOMATOMEDIN BINDING PROTEIN 3; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; TRANSCRIPTION FACTOR RELA; UNINDEXED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; AIR POLLUTANT; AIRBORNE PARTICLE; ALLERGIC DISEASE; ASTHMA; BACTERIAL STRAIN; BLOOD SAMPLING; CELL CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCENTRATION (PARAMETERS); CORONAVIRUS; CYSTIC FIBROSIS; ENZYME ACTIVITY; EXHAUST GAS; FUCOSYLATION; GENE SEQUENCE; GENETIC DISORDER; GLYCOSYLATION; HUMAN; INFECTION; INFLAMMATORY DISEASE; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG DISEASE; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PARTICULATE MATTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEOMICS; PSEUDOMONAS AERUGINOSA; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; SIALYLATION; SPUTUM; SULFATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TOXICOLOGY; TUBERCULOSIS; VERO CELL; VIRUS PNEUMONIA; ANIMAL; BLOOD; COMMUNICABLE DISEASE; HYPERSENSITIVITY; LUNG TUMOR; METABOLISM; METHODOLOGY; URINE;

ANIMALIA;

ANIMALS; BIOLOGICAL MARKERS; COMMUNICABLE DISEASES; CYSTIC FIBROSIS; HUMANS; HYPERSENSITIVITY; LUNG DISEASES; LUNG NEOPLASMS; PROTEOMICS;

EID: 70449729515     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21893     Document Type: Review

References (101)

1. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CF, Krishna S. 2006. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368:1012-1021. (Pubitemid 44353670)
2. Ahn MH, Kang CM, Park CS, Park SJ, Rhim T, Yoon PO, Chang HS, Kim SH, Kyono H, Kim KC. 2005. Titanium dioxide particle-induced goblet cell hyperplasia: Association with mast cells and IL-13. Respir Res 6:34. (Pubitemid 41358036)
3. Bahk YY, Kim SA, Kim JS, Euh HJ, Bai GH, Cho SN, Kim YS. 2004. Antigens secreted from Mycobacterium tuberculosis: Identification by proteomics approach and test for diagnostic marker. Proteomics 4:3299-3307.
4. Barnes PJ, Shapiro SD, Pauwels RA. 2003. Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J 22:672-688. (Pubitemid 37258549)
5. Bensalem N, Ventura AP, Vallée B, Lipecka J, Tondelier D, Davezac N, Dos Santos A, Perretti M, Fajac A, Sermet-Gaudelus I, Renouil M, Lesure JF, Halgand F, Laprévote O, Edelman A. 2005. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol Cell Proteomics 4:1591-1601. (Pubitemid 41555482)
6. Bowden DH. 1976. The pulmonary macrophage. Environ Health Perspect 16:55-60.
7. Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, Giannakis E, Karlsson AS, Silvestrini R, Smallwood D, Vlahos R, Irving LB, Anderson GP. 2008. Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:269-278.
8. Brouillard F, Bensalem N, Hinzpeter A, Tondelier D, Trudel S, Gruber AD, Ollero M, Edelman A. 2005. Blue native/SDS-PAGE analysis reveals reduced expression of the mClCA3 protein in cystic fibrosis knock-out mice. Mol Cell Proteomics 4:1762-1775.
9. Calhoun WJ, Reed HE, Moest DR, Stevens CA. 1992. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 145:317-325.
10. Candiano G, Bruschi M, Pedemonte N, Caci E, Liberatori S, Bini L, Pellegrini C, Viganò M, O'Connor BJ, Lee TH, Galietta LJ, Zegarra-Moran O. 2005. Gelsolin secretion in interleukin-4-treated bronchial epithelia and in asthmatic airways. Am J Respir Crit Care Med 172:1090-1096.
11. Cekanova M, Majidy M, Masi T, Al-Wadei HA, Schuller HM. 2007. Overexpressed Raf-1 and phosphorylated cyclic adenosine 3′-5′- monophosphatate response element-binding protein are early markers for lung adenocarcinoma. Cancer 109:1164-1173.
12. 2 particles. Mol Cell Proteomics 6:56-63.
13. Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH, Yoo YJ. 2001. Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun 289:507-512.
14. Chang CC, Chiu HF, Wu YS, Li YC, Tsai ML, Shen CK, Yang CY. 2005. The induction of vascular endothelial growth factor by ultrafine carbon black contributes to the increase of alveolar-capillary permeability. Environ Health Perspect 113:454-460.
15. Chang CC, Chen SH, Ho SH, Yang CY, Wang HD, Tsai ML. 2007. Proteomic analysis of proteins from bronchoalveolar lavage fluid reveals the action mechanism of ultrafine carbon black-induced lung injury in mice. Proteomics 7:4388-4397.
16. Chang DW, Hayashi S, Gharib SA, Vaisar T, King ST, Tsuchiya M, Ruzinski JT, Park DR, Matute-Bello G, Wurfel MM, Bumgarner R, Heinecke JW, Martin TR. 2008. Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. Am J Respir Crit Care Med 178:701-709.
17. Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. 2002. Proteomic analysis of lung adenocarcinoma: Identification of a highly expressed set of proteins in tumors. Clin Cancer Res 8:2298-2305.
18. Chen JH, Chang YW, Yao CW, Chiueh TS, Huang SC, Chien KY, Chen A, Chang FY, Wong CH, Chen YJ. 2004. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci USA 101:17039-17044.
19. Chung YW, Oh HY, Kim JY, Kim JH, Kim IY. 2004. Allergen-induced proteolytic cleavage of annexin-1 and activation of cytosolic phospholipase A2 in the lungs of a mouse model of asthma. Proteomics 4:3328-3334.
20. Clark-Curtiss JE, Haydel SE. 2003. Molecular genetics of Mycobacterium tuberculosis pathogenesis. Annu Rev Microbiol 57:517-549.
21. de Torre C, Ying SX, Munson PJ, Meduri GU, Suffredini AF. 2006. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics 6:3949-3957.
22. Dechert RE. 2003. The pathophysiology of acute respiratory distress syndrome. Respir Care Clin N Am 9:283-296 vii-viii.
23. Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguière AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Müller S, Rickerts V, Stürmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348:1967-1976. (Pubitemid 36569985)
24. Ezzati M, Henley SJ, Lopez AD, Thun MJ. 2005. Role of smoking in global and regional cancer epidemiology: Current patterns and data needs. Int J Cancer 116:963-971. (Pubitemid 41209205)
25. Frischer T, Myung JK, Maurer G, Eichler I, Szepfalusi Z, Lubec G. 2006. Possible dysregulation of chaperon and metabolic proteins in cystic fibrosis bronchial tissue. Proteomics 6:3381-3388. (Pubitemid 43886154)
26. Gharib TG, Chen G, Wang H, Huang CC, Prescott MS, Shedden K, Misek DE, Thomas DG, Giordano TJ, Taylor JM, Kardia S, Yee J, Orringer MB, Hanash S, Beer DG. 2002. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 4:440-448. (Pubitemid 34976960)
27. Ghosh S, Janocha AJ, Aronica MA, Swaidani S, Comhair SA, Xu W, Zheng L, Kaveti S, Kinter M, Hazen SL, Erzurum SC. 2006. Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J Immunol 176:5587-5597.
28. Gutstein HB, Morris JS. 2007. Laser capture sampling and analytical issues in proteomics. Expert Rev Proteomics 4:627-637.
29. Hendrickson RC, Douglass JF, Reynolds LD, McNeill PD, Carter D, Reed SG, Houghton RL. 2000. Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J Clin Microbiol 38:2354-2361. (Pubitemid 30414364)
30. Hogg JC. 2004. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364:709-721. (Pubitemid 39140629)
31. Horwitz RJ, Busse WW. 1995. Inflammation and asthma. Clin Chest Med 16:583-602.
32. Houghton RL, Lodes MJ, Dillon DC, Reynolds LD, Day CH, McNeill PD, Hendrickson RC, Skeiky YA, Sampaio DP, Badaro R, Lyashchenko KP, Reed SG. 2002. Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. Clin Diagn Lab Immunol 9:883-891. (Pubitemid 34773895)
33. Huang LJ, Chen SX, Huang Y, Luo WJ, Jiang HH, Hu QH, Zhang PF, Yi H. 2006. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer. Lung Cancer 54:87-94.
34. Huard RC, Chitale S, Leung M, Lazzarini LC, Zhu H, Shashkina E, Laal S, Conde MB, Kritski AL, Belisle JT, Kreiswirth BN, Lapa e Silva JR, Ho JL. 2003. The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. Infect Immun 71:6871-6883.
35. Jeong HC, Lee SY, Lee EJ, Jung KH, Kang EH, Lee SY, Kim JH, Park EK, Lee SH, Uhm CS, Cho Y, Shin C, Shim JJ, Kim HK, In KH, Kang KH, Yoo SH. 2007. Proteomic analysis of peripheral T-lymphocytes in patients with asthma. Chest 132:489-496.
36. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. 2005. Cancer statistics. CA Cancer J Clin 55:10-30.
37. Jiang XS, Tang LY, Dai J, Zhou H, Li SJ, Xia QC, Wu JR, Zeng R. 2005. Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approaches: Implications for cellular responses to virus infection. Mol Cell Proteomics 4:902-913. (Pubitemid 41309148)
38. Jung EJ, Avliyakulov NK, Boontheung P, Loo JA, Nel AE. 2007. Pro-oxidative DEP chemicals induce heat shock proteins and an unfolding protein response in a bronchial epithelial cell line as determined by DIGE analysis. Proteomics 7:3906-3918. (Pubitemid 350100007)
39. Kang CM, Jang AS, Ahn MH, Shin JA, Kim JH, Choi YS, Rhim TY, Park CS. 2005. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 33:290-296.
40. Kelsen SG, Duan X, Ji R, PerezO, Liu C, Merali S. 2008. Cigarette smoke induces an unfolded protein response in the human lung: A proteomic approach. Am J Respir Cell Mol Biol 38:541-550. (Pubitemid 351758672)
41. Kips JC, Peleman RA, Pauwels RA. 1998. Methods of examining induced sputum: Do differences matter? Eur Respir J 11:529-533.
42. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ, SARS Working Group. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348:1953-1966. (Pubitemid 36569984)
43. Kunzelmann K, Mall M. 2003. Pharmacotherapy of the ion transport defect in cystic fibrosis: Role of purinergic receptor agonists and other potential therapeutics. Am J Respir Med 2:299-309. (Pubitemid 37045675)
44. Laden F, Neas LM, Dockery DW, Schwartz J. 2000. Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect 108:941-947. (Pubitemid 30950145)
45. Lau AT, Chiu JF. 2007. The possible role of cytokeratin 8 in cadmium-induced adaptation and carcinogenesis. Cancer Res 67:2107-2113. (Pubitemid 46424229)
46. Lau AT, He QY, Chiu JF. 2003. Proteomic technology and its biomedical applications. Acta Biochim Biophys Sin 35:965-975. (Pubitemid 38002241)
47. Lee EJ, In KH, Kim JH, Lee SY, Shin C, Shim JJ, Kang KH, Yoo SH, Kim CH, Kim HK, Lee SH, Uhm CS. 2009. Proteomic analysis in lung tissue of smokers and COPD patients. Chest 135:344-352.
48. Lei T, He QY, Wang YL, Si LS, Chiu JF. 2008. Heparin chromatography to deplete high-abundance proteins for serum proteomics. Clin Chim Acta 388:173-178. (Pubitemid 50010701)
49. Li XY, Gilmour PS, Donaldson K, MacNee W. 1996. Free radical activity and proinflammatory effects of particulate air pollution (PM10) in vivo and in vitro. Thorax 51:1216-1222. (Pubitemid 26413140)
50. Li C, Xiao Z, Chen Z, Zhang X, Li J, Wu X, Li X, Yi H, Li M, Zhu G, Liang S. 2006. Proteome analysis of human lung squamous carcinoma. Proteomics 6:547-558. (Pubitemid 43208034)
51. Liu Y, Chen Q, Zhang JT. 2004. Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling. J Proteome Res 3:728-735. (Pubitemid 39166232)
52. Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF, Li C, Li F, Chen YH, Yi H, Yao HX, Chen ZC. 2009. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 217:54-64.
53. Lou X, Xiao T, Zhao K, Wang H, Zheng H, Lin D, Lu Y, Gao Y, Cheng S, Liu S, Xu N. 2007. Cathepsin D is secreted from M-BE cells: Its potential role as a biomarker of lung cancer. J Proteome Res 6:1083-1092. (Pubitemid 46480472)
54. Maddox L, Schwartz DA. 2002. The pathophysiology of asthma. Annu Rev Med 53:477-498.
55. Mattow J, Siejak F, Hagens K, Becher D, Albrecht D, Krah A, Schmidt F, Jungblut PR, Kaufmann SH, Schaible UE. 2006. Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 6:2485-2494.
56. McMorran BJ, Patat SA, Carlin JB, Grimwood K, Jones A, Armstrong DS, Galati JC, Cooper PJ, Byrnes CA, Francis PW, Robertson CF, Hume DA, Borchers CH, Wainwright CE, Wainwright BJ. 2007. Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. Clin Chem 53:1782-1791. (Pubitemid 47509671)
57. Merkel D, Rist W, Seither P, Weith A, Lenter MC. 2005. Proteomic study of human bronchoalveolar lavage fluids from smokerswith chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics 5:2972-2980. (Pubitemid 41059773)
58. Oberdörster G, Utell MJ. 2002. Ultrafine particles in the urban air: To the respiratory tract-And beyond? Environ Health Perspect 110:A440-A441.
59. Ohlmeier S, Vuolanto M, Toljamo T, Vuopala K, Salmenkivi K, Myllarniemi M, Kinnula VL. 2008. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 7:5125-5132.
60. Pagan I, Costa DL, McGee JK, Richards JH, Dye JA. 2003. Metals mimic airway epithelial injury induced by in vitro exposure to Utah Valley ambient particulate matter extracts. J Toxicol Environ Health A 66:1087-1112. (Pubitemid 36859666)
61. Pang RT, Poon TC, Chan KC, Lee NL, Chiu RW, Tong YK, Wong RM, Chim SS, Ngai SM, Sung JJ, Lo YM. 2006. Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome. Clin Chem 52:421-429. (Pubitemid 43306465)
62. Park JH, Kim YS, Lee HL, Shim JY, Lee KS, Oh YJ, Shin SS, Choi YH, Park KJ, Park RW, Hwang SC. 2006. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 11:269-275.
63. Patz EF, Jr., Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE II. 2007. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 25:5578-5583.
64. Pedersen SK, Sloane AJ, Prasad SS, Sebastian LT, Lindner RA, Hsu M, Robinson M, Bye PT, Weinberger RP, Harry JL. 2005. An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: Application to cystic fibrosis. Mol Cell Proteomics 4:1052-1060. (Pubitemid 41223365)
65. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY, SARS study group. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325.
66. Penney DP. 1988. The ultrastructure of epithelial cells of the distal lung. Int Rev Cytol 111:231-269.
67. Pollard HB, Ji XD, Jozwik C, Jacobowitz DM. 2005. High abundance protein profiling of cystic fibrosis lung epithelial cells. Proteomics 5:2210-2226. (Pubitemid 40770583)
68. Pollard HB, Eidelman O, Jozwik C, Huang W, Srivastava M, Ji XD, McGowan B, Norris CF, Todo T, Darling T, Mogayzel PJ, Zeitlin PL, Wright J, Guggino WB, Metcalf E, Driscoll WJ, Mueller G, Paweletz C, Jacobowitz DM. 2006. De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cells. Mol Cell Proteomics 5:1628-1637. (Pubitemid 44480390)
69. Ren Y, He QY, Fan J, Jones B, Zhou Y, Xie Y, Cheung CY, Wu A, Chiu JF, Peiris JS, Tam PK. 2004. The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome. Proteomics 4:3477-3484. (Pubitemid 39525298)
70. Renauld JC. 2001. New insights into the role of cytokines in asthma. JClin Pathol 54:577-589. (Pubitemid 32756438)
71. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. 2000. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 343:1742-1749. (Pubitemid 32369215)
72. Schapira RM, Ghio AJ, Effros RM, Morrisey J, Almagro UA, Dawson CA, Hacker AD. 1995. Hydroxyl radical production and lung injury in the rat following silica or titanium dioxide instillation in vivo. Am J Respir Cell Mol Biol 12:220-226.
73. Schnapp LM, Donohoe S, Chen J, Sunde DA, Kelly PM, Ruzinski J, Martin T, Goodlett DR. 2006. Mining the acute respiratory distress syndrome proteome: Identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol 169:86-95.
74. Schulz BL, Sloane AJ, Robinson LJ, Prasad SS, Lindner RA, Robinson M, Bye PT, Nielson DW, Harry JL, Packer NH, Karlsson NG. 2007. Glycosylation of sputum mucins is altered in cystic fibrosis patients. Glycobiology 17:698-712.
75. Sloane AJ, Lindner RA, Prasad SS, Sebastian LT, Pedersen SK, Robinson M, Bye PT, Nielson DW, Harry JL. 2005. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Am J Respir Crit Care Med 172:1416-1426.
76. Srivastava S, Kramer B, Hansen HH, editors. 1994. Lung cancer. Norwell: Kluwer Academic Publishers. pp 91-110.
77. Srivastava M, Eidelman O, Jozwik C, Paweletz C, Huang W, Zeitlin PL, Pollard HB. 2006. Serum proteomic signature for cystic fibrosis using an antibody microarray platform. Mol Genet Metab 87:303-310.
78. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, Boucher RC. 1995. CFTR as a cAMP-dependent regulator of sodium channels. Science 269:847-850.
79. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, Sykes AM, Aughenbaugh GL, Bungum AO, Allen KL. 2005. CT screening for lung cancer: Five-year prospective experience. Radiology 235:259-265.
80. Tantipaiboonwong P, Sinchaikul S, Sriyam S, Phutrakul S, Chen ST. 2005. Different techniques for urinary protein analysis of normal and lung cancer patients. Proteomics 5:1140-1149.
81. Tian T, Hao J, Xu A, Hao J, Luo C, Liu C, Huang L, Xiao X, He D. 2007. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 98:1265-1274.
82. Tsui LC. 1995. The cystic fibrosis transmembrane conductance regulator gene. Am J Respir Crit Care Med 151:S47-S53.
83. Wan J, Sun W, Li X, Ying W, Dai J, Kuai X, Wei H, Gao X, Zhu Y, Jiang Y, Qian X, He F. 2006. Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase. Proteomics 6:2886-2894. (Pubitemid 43752048)
84. Wang Y, Chiu JF, He QY. 2008. Isolation of cytoplasmatic proteins from cultured cells for two-dimensional gel electrophoresis. Methods Mol Biol 425:101-112.
85. Ware LB, Matthay MA. 2000. The acute respiratory distress syndrome. N Engl J Med 342:1334-1349.
86. Warheit DB, Hansen JF, Yuen IS, Kelly DP, Snajdr SI, Hartsky MA. 1997. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol Appl Pharmacol 145:10-22.
87. Wattiez R, Falmagne P. 2005. Proteomics of bronchoalveolar lavage fluid. J Chromatogr B Analyt Technol Biomed Life Sci 815:169-178.
88. Weibel ER, Gomez DM. 1962. Architecture of the human lung. Use of quantitative methods establishes fundamental relations between size and number of lung structures. Science 137:577-585.
89. Widdicombe JH. 2002. Regulation of the depth and composition of airway surface liquid. J Anat 201:313-318. (Pubitemid 35244050)
90. World Health Organization. 2008. The top 10 causes of death. http://www.who.int/ mediacentre/factsheets/fs310/en/print.html.
91. Xiao GG, Wang M, Li N, Loo JA, Nel AE. 2003. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem 278:50781-50790. (Pubitemid 37548927)
92. Yeo S, Roh GS, Kim DH, Lee JM, Seo SW, Cho JW, Kim CW, Kwack K. 2004. Quantitative profiling of plasma peptides in asthmatic mice using liquid chromatography and mass spectrometry. Proteomics 4:3308-3317. (Pubitemid 39525278)
93. Ying W, Hao Y, Zhang Y, Peng W, Qin E, Cai Y, Wei K, Wang J, Chang G, Sun W, Dai S, Li X, Zhu Y, Li J, Wu S, Guo L, Dai J, Wang J, Wan P, Chen T, Du C, Li D, Wan J, Kuai X, Li W, Shi R, Wei H, Cao C, Yu M, Liu H, Dong F, Wang D, Zhang X, Qian X, Zhu Q, He F. 2004. Proteomic analysis on structural proteins of severe acute respiratory syndrome coronavirus. Proteomics 4:492-504. (Pubitemid 38235269)
94. Yip TT, Chan JW, Cho WC, Yip TT, Wang Z, Kwan TL, Law SC, Tsang DN, Chan JK, Lee KC, Cheng WW, Ma VW, Yip C, Lim CK, Ngan RK, Au JS, Chan A, Lim WW, Ciphergen SARS Proteomics Study Group. 2005. Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid A protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem 51:47-55.
95. Zeng R, Ruan HQ, Jiang XS, Zhou H, Shi L, Zhang L, Sheng QH, Tu Q, Xia QC, Wu JR. 2004a. Proteomic analysis of SARS associated coronavirus using two-dimensional liquid chromatography mass spectrometry and one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by mass spectroemtric analysis. J Proteome Res 3:549-555. (Pubitemid 39207359)
96. Zeng R, Yang RF, Shi MD, Jiang MR, Xie YH, Ruan HQ, Jiang XS, Shi L, Zhou H, Zhang L, Wu XD, Lin Y, Ji YY, Xiong L, Jin Y, Dai EH, Wang XY, Si BY, Wang J, Wang HX, Wang CE, Gan YH, Li YC, Cao JT, Zuo JP, Shan SF, Xie E, Chen SH, Jiang ZQ, Zhang X, Wang Y, Pei G, Sun B, Wu JR. 2004b. Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients. J Mol Biol 341:271-279.
97. Zhang L, Wang M, Kang X, Boontheung P, Li N, Nel AE, Loo JA. 2009. Oxidative stress and asthma: Proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J Proteome Res 8:1631-1638.
98. Zhao J, Zhu H, Wong CH, Leung KY, Wong WS. 2005. Increased lungkine and chitinase levels in allergic airway inflammation: A proteomics approach. Proteomics 5:2799-2807.
99. Zhou Y, McLane M, Levitt RC. 2001. Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthma. Respir Res 2:80-84.
100. Zhu H, Hu S, Jona G, Zhu X, Kreiswirth N, Willey BM, Mazzulli T, Liu G, Song Q, Chen P, Cameron M, Tyler A, Wang J, Wen J, Chen W, Compton S, Snyder M. 2006. Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc Natl Acad Sci USA 103:4011-4016.
101. Zielenski J, Tsui LC. 1995. Cystic fibrosis: Genotypic and phenotypic variations. Annu Rev Genet 29:777-807.